9 results
Myasthenia Gravis Overview

Myasthenia Gravis is an autoimmune disorder of the postsynaptic neuromuscular junction.  Ab to
weakness in: 1. ... EMG Findings: 1. ... - Peek sign ... Imaging - CT Chest ... Gravis #diagnosis #management
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
typically fall into 1 ... with presence of pulmonary ... #differential #algorithm ... #management #cardiology ... heartfailure #chf #criticalcare
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
GrepMed Handbook Clinical ... post-ABx, but can ... equivocal • CT ... • Flex-Sig: If ... 10 mg/kg IV x 1
Pulmonary Nodule
Evaluation is guided by nodule size & assessment of probability of malignancy. In addition is
malignancy is < 1% ... nodules < 6 mm and 1% ... lung malignancy, clinical ... The treatment of ... Management options
General schema for respiratory support in patients with COVID-19
Low flow nasal cannula
 • Typically set at
Typically set at 1- ... filter • N95 mask ... support #COVID19 #management ... #schema #criticalcare ... hypoxia #failure #algorithm
Community Acquired Pneumonia (CAP) - Diagnosis and Management

Pneumonia Signs/Symptoms:
 • Confusion/disorientation (LR + 1.9)
 • Cough
Diagnosis and Management ... Pneumonia Signs ... Egophony (May appear 1- ... radiograph or CT ... #treatment #Pulmonary
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
murmur 3/6) - Pulmonary ... event, follow ACC algorithm ... Change in clinical ... one post op Cardiology ... medical and surgical management
Perhaps quite too often, the knee-jerk reaction to an elevated Troponin is to call our friends
our friends from Cardiology ... #diagnosis #algorithm ... #management #clinical ... #criticalcare # ... foamed #treatment
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
Epidemiology: • F > M: 9:1 ... salivary ducts Clinical ... phenomenon (16%) MSK ... Adenocarcinoma Treatment ... Rheumatology #Diagnosis #Management